| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |